ProShares Ultra Nasdaq Biotechnology (BIB) Holdings $55.43 +0.78 (+1.43%) As of 03:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Top 25 BIB HoldingsRankCompanyCurrent PriceWeightShares Held1NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGN/A31.61%3,6752NASDAQ BIO INDEX SWAP BNP PARIBASN/A28.95%3,3653NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAN/A26.90%3,1274NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEN/A16.55%1,9245NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONALN/A16.51%1,9196NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAN/A16.30%1,8957GILDGilead Sciences$114.35+0.2%4.60%22,0918AMGNAmgen$289.08+0.2%4.50%8,4389REGNRegeneron Pharmaceuticals$583.71+2.0%3.96%3,69610VRTXVertex Pharmaceuticals$388.27-0.2%3.95%5,500 Get the Latest News and Ratings for BIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 11ALNYAlnylam Pharmaceuticals$450.23+1.5%3.30%3,99412AZNAstraZeneca$79.91+0.3%3.05%20,75813INSMInsmed$131.41+2.4%1.53%6,40314ARGXargenex$705.38+4.1%1.33%1,10815BIIBBiogen$136.05-0.2%1.30%5,15016SMMTSummit Therapeutics$26.85+2.2%1.24%26,10217INCYIncyte$83.89-1.0%1.05%6,80218ILMNIllumina$98.79-0.9%1.03%5,56319RPRXRoyalty Pharma$35.85-0.4%0.98%14,80920SNYSanofi$50.21+0.1%0.92%9,89121UTHRUnited Therapeutics$306.12+0.2%0.90%1,58422NBIXNeurocrine Biosciences$136.70+2.0%0.86%3,47923TEMTempus AI$74.86-1.4%0.86%5,90824MEDPMedpace$467.50+0.1%0.85%1,01125ONCBeOne Medicines$307.34-0.4%0.83%1,453 Geographic ExposureUnited States70.6%Ireland0.9%Bermuda0.5%Netherlands0.5%Canada0.4%Switzerland0.3%United Kingdom0.3%Luxembourg0.1%Singapore0.1%Jersey0.1%Israel0.1%Currency ExposureUSD82.4%Sector ExposureHealth Care63.4%Consumer Discretionary0.8%Energy0.1%Biotechnology0.1%Industrials0.1%Life Sciences Tools & Services0.1%Industry ExposureBiotechnology56.4%Pharmaceuticals3.5%Health Care Equipment & Supplies1.6%Diversified Consumer Services1.4%Life Sciences Tools & Services1.2%Distributors0.2%Renewable Energy0.1%Commercial Services & Supplies0.1%SubIndustry ExposureBiotechnology54.0%Pharmaceuticals4.2%Life Sciences Tools & Services3.5%Renewable Energy Equipment0.1%Health Care Supplies0.1%Health Care Equipment0.1% Related Companies and Tools Related Companies F/m Emerald Life Sciences Innovation ETF Top Holdings Global X HealthTech ETF Top Holdings Invesco Nasdaq Biotechnology ETF Top Holdings Invesco Dorsey Wright Healthcare Momentum ETF Top Holdings Horizon Kinetics Medical ETF Top Holdings First Trust Nasdaq Pharmaceuticals ETF Top Holdings T. Rowe Price Health Care ETF Top Holdings JPMorgan Healthcare Leaders ETF Top Holdings ProShares UltraShort Nasdaq Biotechnology Top Holdings Invesco S&P SmallCap Health Care ETF Top Holdings This page (NASDAQ:BIB) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access